Correction: Essential role of TEA domain transcription factors in the negative regulation of the MYH 7 gene by thyroid hormone and its receptors (PLoS ONE (2014) 9, 4 (e88610) DOI: 10.1371/journal.pone.0088610);Essential role of TEA domain transcription factors in the negative regulation of the MYH 7 gene by thyroid hormone and its receptors

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Iwaki, Hiroyuki ^a,c   Sasaki, Shigekazu ^a   Matsushita, Akio ^a   Ohba, Kenji ^a   Matsunaga, Hideyuki ^a   Misawa, Hiroko ^a   Oki, Yutaka ^a   Ishizuka, Keiko ^a   Nakamura, Hirotoshi ^b   Suda, Takafumi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KUMA HOSPITAL   (Japan)

^c SEIREI HAMAMATSU GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; LIOTHYRONINE RECEPTOR; LIOTHYRONINE RECEPTOR ALPHA1; LIOTHYRONINE RECEPTOR BETA1; MYOSIN HEAVY CHAIN BETA; SOBETIROME; TEA DOMAIN TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; MYH7 PROTEIN, RAT; MYOSIN HEAVY CHAIN; PRIMER DNA; THYROID HORMONE RECEPTOR;

ANIMAL CELL; ARTICLE; AT RICH SEQUENCE; CONTROLLED STUDY; DNA BINDING MOTIF; EMBRYO; GENE CONTROL; GENE REPRESSION; HAPLORHINI; MCAT SITE; MYH7 GENE; NEWBORN; NONHUMAN; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RAT; RECEPTOR BINDING; RNA INTERFERENCE; TRANSACTIVATION; TRANSCRIPTION TERMINATION; TRANSCRIPTIONAL ENHANCER FACTOR DOMAIN; ANIMAL; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; GENE EXPRESSION REGULATION; HUMANS; MYOSIN HEAVY CHAINS; PROMOTER REGIONS, GENETIC; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, THYROID HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION FACTORS; TRIIODOTHYRONINE;

EID: 84899767623     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106385     Document Type: Erratum

References (71)

1. Morkin E (1993) Regulation of myosin heavy chain genes in the heart. Circulation 87:1451-60
2. Gupta MP (2007) Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J Mol Cell Cardiol 43:388-403
3. Herron TJ, McDonald KS (2002) Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ Res 90:1150-2 (Pubitemid 34786898)
4. Kinugawa K, Minobe WA, Wood WM, Ridgway EC, Baxter JD, et al. (2001) Signaling pathways responsible for fetal gene induction in the failing human heart: evidence for altered thyroid hormone receptor gene expression. Circulation 103:1089-94 (Pubitemid 32200182)
5. Ojamaa K, Kenessey A, Shenoy R, Klein I (2000) Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat. Am J Physiol Endocrinol Metab 279:E1319-24
6. Dillmann W (2010) Cardiac hypertrophy and thyroid hormone signaling. Heart Fail Rev 15:125-32
7. Kahaly GJ, Dillmann WH (2005) Thyroid hormone action in the heart. Endocr Rev 26:704-28 (Pubitemid 41127279)
8. Kinugawa K, Yonekura K, Ribeiro RC, Eto Y, Aoyagi T, et al. (2001) Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ Res 89:591-8 (Pubitemid 32924213)
9. Trivieri MG, Oudit GY, Sah R, Kerfant BG, Sun H, et al. (2006) Cardiacspecific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc Natl Acad Sci U S A 103:6043-8
10. Belke DD, Gloss B, Swanson EA, Dillmann WH (2007) Adeno-associated virusmediated expression of thyroid hormone receptor isoforms-alpha1 and -beta1 improves contractile function in pressure overload-induced cardiac hypertrophy. Endocrinology 148:2870-7 (Pubitemid 46984823)
11. Cheng SY, Leonard JL, Davis PJ (2010) Molecular aspects of thyroid hormone actions. Endocr Rev 31:139-70
12. Haddad F, Qin AX, McCue SA, Baldwin KM (1998) Thyroid receptor plasticity in striated muscle types: effects of altered thyroid state. Am J Physiol 274:E1018-26
13. Sadow PM, Chassande O, Koo EK, Gauthier K, Samarut J, et al. (2003) Regulation of expression of thyroid hormone receptor isoforms and coactivators in liver and heart by thyroid hormone. Mol Cell Endocrinol 203:65-75 (Pubitemid 36627589)
14. Baxter JD, Webb P, Grover G, Scanlan TS (2004) Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weight. Trends Endocrinol Metab 15:154-7 (Pubitemid 38510494)
15. Lee Y, Mahdavi V (1993) The D domain of the thyroid hormone receptor alpha 1 specifies positive and negative transcriptional regulation functions. J Biol Chem 268:2021-8 (Pubitemid 23033609)
16. Sasaki S, Matsushita A, Nakamura H (2011) Negative regulation of the thyrotropin beta gene by thyroid hormone. Contemporary Aspects of Endocrinology http://www.intechopen.com/books/contemporary-aspects-ofendocrinology: pp. 101-138
17. Chen W, Roeder RG (2011) Mediator-dependent nuclear receptor function. Semin Cell Dev Biol 22:749-58
18. Misawa H, Sasaki S, Matsushita A, Ohba K, Iwaki H, et al. (2012) Liganded thyroid hormone receptor inhibits phorbol 12-O-tetradecanoate-13-acetateinduced enhancer activity via firefly luciferase cDNA. PLoS One 7:e28916
19. Nishi H, Ono K, Horie T, Nagao K, Kinoshita M, et al. (2011) MicroRNA-27a regulates beta cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor beta1 in neonatal rat ventricular myocytes. Mol Cell Biol 31:744-55
20. Mansen A, Yu F, Forrest D, Larsson L, Vennstrom B (2001) TRs have common and isoform-specific functions in regulation of the cardiac myosin heavy chain genes. Mol Endocrinol 15:2106-14 (Pubitemid 33141130)
21. Wright CE, Haddad F, Qin AX, Bodell PW, Baldwin KM (1999) In vivo regulation of beta-MHC gene in rodent heart: role of T3 and evidence for an upstream enhancer. Am J Physiol 276:C883-91 (Pubitemid 29211317)
22. Cohen RN, Wondisford FE (2013) Factors that control thyroid function: Chemistry and Biosynthesis of Thyrotropin. Werner and Ingbar's The Thyroid Tenth Edition: pp149-161
23. Wondisford FE, Farr EA, Radovick S, Steinfelder HJ, Moates JM, et al. (1989) Thyroid hormone inhibition of human thyrotropin beta-subunit gene expression is mediated by a cis-acting element located in the first exon. J Biol Chem 264:14601-4 (Pubitemid 19237269)
24. Gordon DF, Sarapura VD, Samuels MH, Ridgway EC (2010) Thyroid- Stimulating Hormone: Physiology and Secretion (Chapter 73). Endocrinology, Adult and Pediatric, Expert Consult Premium Edition, 6th edition Volume 2: pp1362-1383
25. Jensen FC, Girardi AJ, Gilden RV, Koprowski H (1964) Infection Of Human And Simian Tissue Cultures With Rous Sarcoma Virus. Proc Natl Acad Sci US A 52:53-9
26. Nakano K, Matsushita A, Sasaki S, Misawa H, Nishiyama K, et al. (2004) Thyroid-hormone-dependent negative regulation of thyrotropin beta gene by thyroid hormone receptors: study with a new experimental system using CV1 cells. Biochem J 378:549-57 (Pubitemid 38367244)
27. Matsushita A, Sasaki S, Kashiwabara Y, Nagayama K, Ohba K, et al. (2007) Essential role of GATA2 in the negative regulation of thyrotropin beta gene by thyroid hormone and its receptors. Mol Endocrinol 21:865-84 (Pubitemid 46984728)
28. Thompson WR, Nadal-Ginard B, Mahdavi V (1991) A MyoD1-independent muscle-specific enhancer controls the expression of the beta-myosin heavy chain gene in skeletal and cardiac muscle cells. J Biol Chem 266:22678-88 (Pubitemid 21908703)
29. Shimizu N, Dizon E, Zak R (1992) Both muscle-specific and ubiquitous nuclear factors are required for muscle-specific expression of the myosin heavy-chain beta gene in cultured cells. Mol Cell Biol 12:619-30
30. Knotts S, Rindt H, Neumann J, Robbins J (1994) In vivo regulation of the mouse beta myosin heavy chain gene. J Biol Chem 269:31275-82 (Pubitemid 24377628)
31. Karasseva N, Tsika G, Ji J, Zhang A, Mao X, et al. (2003) Transcription enhancer factor 1 binds multiple muscle MEF2 and A/T-rich elements during fast-to-slow skeletal muscle fiber type transitions. Mol Cell Biol 23:5143-64 (Pubitemid 36950871)
32. Yoshida T (2008) MCAT elements and the TEF-1 family of transcription factors in muscle development and disease. Arterioscler Thromb Vasc Biol 28:8-17
33. Yasunami M, Suzuki K, Ohkubo H (1996) A novel family of TEA domain-containing transcription factors with distinct spatiotemporal expression patterns. Biochem Biophys Res Commun 228:365-70 (Pubitemid 26396080)
34. Maeda T, Gupta MP, Stewart AF (2002) TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. Biochem Biophys Res Commun 294:791-7 (Pubitemid 34687186)
35. Tsika RW, Ma L, Kehat I, Schramm C, Simmer G, et al. (2010) TEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction. J Biol Chem 285:13721-35
36. Maeda T, Mazzulli JR, Farrance IK, Stewart AF (2002) Mouse DTEF-1 (ETFR-1, TEF-5) is a transcriptional activator in alpha 1-adrenergic agonist-stimulated cardiac myocytes. J Biol Chem 277:24346-52 (Pubitemid 34951955)
37. Kariya K, Karns LR, Simpson PC (1994) An enhancer core element mediates stimulation of the rat beta-myosin heavy chain promoter by an alpha 1- adrenergic agonist and activated beta-protein kinase C in hypertrophy of cardiac myocytes. J Biol Chem 269:3775-82
38. Ojamaa K, Klemperer JD, MacGilvray SS, Klein I, Samarel A (1996) Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart. Endocrinology 137:802-8 (Pubitemid 26074126)
39. Rindt H, Knotts S, Robbins J (1995) Segregation of cardiac and skeletal muscle-specific regulatory elements of the beta-myosin heavy chain gene. Proc Natl Acad Sci U S A 92:1540-4
40. Kimes BW, Brandt BL (1976) Properties of a clonal muscle cell line from rat heart. Exp Cell Res 98:367-81
41. Samuels HH, Stanley F, Casanova J (1979) Depletion of L-3,5,39-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105:80-5 (Pubitemid 9199127)
42. Tinnikov A, Nordstrom K, Thoren P, Kindblom JM, Malin S, et al. (2002) Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1. Embo J 21:5079-87
43. De Bosscher K, Vanden Berghe W, Haegeman G (2003) The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 24:488-522 (Pubitemid 37059110)
44. Kassel O, Herrlich P (2007) Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol Cell Endocrinol 275:13-29 (Pubitemid 47259283)
45. Uhlenhaut NH, Barish GD, Yu RT, Downes M, Karunasiri M, et al. (2013) Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol Cell 49:158-71
46. Meischl C, Buermans HP, Hazes T, Zuidwijk MJ, Musters RJ, et al. (2008) H9c2 cardiomyoblasts produce thyroid hormone. Am J Physiol Cell Physiol 294:C1227-33
47. Trost SU, Swanson E, Gloss B, Wang-Iverson DB, Zhang H, et al. (2000) The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. Endocrinology 141:3057-64 (Pubitemid 32268991)
48. Venditti P, Chiellini G, Bari A, Di Stefano L, Zucchi R, et al. (2009) T3 and the thyroid hormone beta-receptor agonist GC-1 differentially affect metabolic capacity and oxidative damage in rat tissues. J Exp Biol 212:986-93
49. Makino A, Suarez J, Wang H, Belke DD, Scott BT, et al. (2009) Thyroid hormone receptor-beta is associated with coronary angiogenesis during pathological cardiac hypertrophy. Endocrinology 150:2008-15
50. Ladenson PW, Sherman SI, Baughman KL, Ray PE, Feldman AM (1992) Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proc Natl Acad Sci U S A 89:5251-5
51. Kawana M, Kimata S, Hosoda S (1994) The change in expression of cardiac myosin isozymes by the stimulation of the sympathetic nerve and thyroxine. The Adapted Heart: pp393-401
52. Khoury SF, Hoit BD, Dave V, Pawloski-Dahm CM, Shao Y, et al. (1996) Effects of thyroid hormone on left ventricular performance and regulation of contractile and Ca(2+)-cycling proteins in the baboon. Implications for the force-frequency and relaxation-frequency relationships. Circ Res 79:727-35 (Pubitemid 26317820)
53. Everett AW, Sinha AM, Umeda PK, Jakovcic S, Rabinowitz M, et al. (1984) Regulation of myosin synthesis by thyroid hormone: relative change in the alpha- and beta-myosin heavy chain mRNA levels in rabbit heart. Biochemistry 23:1596-9 (Pubitemid 14139807)
54. Magner JA, Clark W, Allenby P (1988) Congestive heart failure and sudden death in a young woman with thyrotoxicosis. West J Med 149:86-91
55. Pandya K, Kim HS, Smithies O (2006) Fibrosis, not cell size, delineates betamyosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo. Proc Natl Acad Sci U S A 103:16864-9 (Pubitemid 44737344)
56. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, et al. (2007) Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316:575-9 (Pubitemid 46683138)
57. Vyas DR, McCarthy JJ, Tsika RW (1999) Nuclear protein binding at the betamyosin heavy chain A/T-rich element is enriched following increased skeletal muscle activity. J Biol Chem 274:30832-42
58. Durocher D, Charron F, Warren R, Schwartz RJ, Nemer M (1997) The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. Embo J 16:5687-96 (Pubitemid 27399860)
59. Danzi S, Klein I (2005) Posttranscriptional regulation of myosin heavy chain expression in the heart by triiodothyronine. Am J Physiol Heart Circ Physiol 288:H455-60 (Pubitemid 40139625)
60. Haddad F, Qin AX, Bodell PW, Jiang W, Giger JM, et al. (2008) Intergenic transcription and developmental regulation of cardiac myosin heavy chain genes. Am J Physiol Heart Circ Physiol 294:H29-40
61. Edwards JG, Bahl JJ, Flink IL, Cheng SY, Morkin E (1994) Thyroid hormone influences beta myosin heavy chain (beta MHC) expression. Biochem Biophys Res Commun 199:1482-8
62. Haddad F, Jiang W, Bodell PW, Qin AX, Baldwin KM (2010) Cardiac myosin heavy chain gene regulation by thyroid hormone involves altered histone modifications. Am J Physiol Heart Circ Physiol 299:H1968-80
63. Pandya K, Pulli B, Bultman S, Smithies O (2011) Reversible epigenetic modifications of the two cardiac myosin heavy chain genes during changes in expression. Gene Expr 15:51-9
64. Pei L, Leblanc M, Barish G, Atkins A, Nofsinger R, et al. (2011) Thyroid hormone receptor repression is linked to type I pneumocyte-associated respiratory distress syndrome. Nat Med 17:1466-72
65. Gilchrist DA, Dos Santos G, Fargo DC, Xie B, Gao Y, et al. (2010) Pausing of RNA polymerase II disrupts DNA-specified nucleosome organization to enable precise gene regulation. Cell 143:540-51
66. Chen W, Zhang X, Birsoy K, Roeder RG (2011) A muscle-specific knockout implicates nuclear receptor coactivator MED1 in the regulation of glucose and energy metabolism. Proc Natl Acad Sci U S A 107:10196-201
67. De K, Ghosh G, Datta M, Konar A, Bandyopadhyay J, et al. (2004) Analysis of differentially expressed genes in hyperthyroid-induced hypertrophied heart by cDNA microarray. J Endocrinol 182:303-14 (Pubitemid 39199014)
68. Adamson C, Maitra N, Bahl J, Greer K, Klewer S, et al. (2004) Regulation of gene expression in cardiomyocytes by thyroid hormone and thyroid hormone analogs 3,5-diiodothyropropionic acid and CGS 23425 [N-[3,5-dimethyl-4- (4′- hydroxy-3′-isopropylphenoxy)-phenyl]-oxamic acid]. J Pharmacol Exp Ther 311:164-71 (Pubitemid 39287796)
69. Fukuyama K, Ichiki T, Takeda K, Tokunou T, Iino N, et al. (2003) Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone. Hypertension 41:598-603 (Pubitemid 36314638)
70. Maeda T, Chapman DL, Stewart AF (2002) Mammalian vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation. J Biol Chem 277:48889-98 (Pubitemid 35470858)
71. Ohba K, Sasaki S, Matsushita A, Iwaki H, Matsunaga H, et al. (2011) GATA2 mediates thyrotropin-releasing hormone-induced transcriptional activation of the thyrotropin beta gene. PLoS One 6:e18667